相关实验视频

Updated: Jun 5, 2025

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

胰岛素耐药性作为腰椎脊柱狭窄症中黄膜缩的危险因素

Yoshihito Sakai¹, Norimitsu Wakao¹, Hiroki Matsui¹

¹Department of Orthopaedic Surgery, National Center for Geriatrics and Gerontology, Obu, Japan.

Spine surgery and related research

|December 11, 2024

概括

胰岛素耐药性与带 (LF) 缩有关,这是腰椎缩症 (LSS) 的关键因素. 这一发现表明在LSS治疗中控制胰岛素耐药性的潜在作用.

科学领域:

生物医学研究的研究.
整形外科整形外科整形外科
内分泌学在内分泌学.

背景情况:

带 (LF) 缩是腰椎狭窄症 (LSS) 的主要原因,但其分子基础尚未完全理解.
之前的研究已经确定了胰岛素受体和TGFβ信号通路在LF缩.
这项研究调查了内源性胰岛素在LSS患者中LF缩中的作用.

研究的目的:

为了检查胰岛素耐药性和LF缩在LSS患者之间的关系.
为了确定胰岛素抵抗是否是LF缩的重要危险因素.

主要方法:

对1,119名患有LSS的患者 (≥65岁) 的分析.
从MRI计算管比率 (FCR) 并使用HOMA-IR评估胰岛素耐药性.
包括条件后勤回归在内的统计分析.

主要成果:

在51%的LSS患者中观察到LF缩,与更高的年龄,男性比例,糖尿病,BMI,HOMA-IR和肌素相关.
患有胰岛素耐药症的患者表现出明显更高的LF缩 (47.1%) 和更高的FCR.
HOMA-IR被确定为LF缩的重要因素,独立于年龄.

结论:

在LSS患者中,LF缩和胰岛素抵抗之间存在显著的关联.
脊髓纤维缩可能涉及炎症触发的弹性纤维退化,可能与与年龄相关的炎症变化有关.
控制胰岛素耐药性可能是LSS的治疗目标.

关键词:

胰岛素耐药性胰岛素耐药性是一种带的带 (Ligamentum flavum) 是一个带.腰椎脊柱狭窄症腰椎脊柱狭窄症病理学病理学病理学

更多相关视频

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes

Published on: June 25, 2017

相关概念视频

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...